GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Finasteride - BPH 5 mg tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Renal Drug Handbook, fifth edition

Product / population
Historical 2019 reference; renal bands retain the book's own method labels.
Renal method
Not specified
Source revision
Not established
Retrieved
2026-09-05
Local review status
Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.
Handbook

Renal Drug Handbook, fifth edition

UK Renal Pharmacy Group / Ashley and Dunleavy / CRC Press · Historical 2019 reference; renal bands retain the book's own method labels.

Renal method: Not specified in this summary.
Source date: Not established
Retrieved: 2026-09-05

Historical handbook facts locally summarized; not a current U.S. label or a modern CRRT protocol.

Renal-function and renal-replacement summary

The 20-50, 10-20 and <10 mL/min bands retain the normal dose. APD/CAPD, HD and CAV/VVHD are considered unlikely to remove finasteride; high-flux removal is unknown. The book retains normal dosing across these modalities.

finasteride-bph:rdh5-429-1 · Source locator: Dose in renal impairment; Dose in renal replacement

Lower-range evidence

The book notes label data down to CrCl 9 mL/min and no studies below 9. This is an evidence limitation rather than a studied-dose guarantee at every lower value.

finasteride-bph:rdh5-429-2 · Source locator: Other information

Source identity and provenance
Retrieved
2026-09-05
Handbook page
Printed page 429; PDF page 448
Hash meaning
Locally authored source summary, not original SPL/XML/PDF bytes
Local summary SHA-256
e80a026fa82614b513f152aa3b4a391f6e642685c1075cf1b24917f189bb3202

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=finasteride-bph&s1=rdh5-429&h1=82ebd63d41821d2a7f12f1813d621efa5224f7d9d08215ea03c48f0ee1d1c500